Detalhe da pesquisa
1.
Interaction with ErbB4 promotes hypoxia-inducible factor-1α signaling.
J Biol Chem
; 287(13): 9659-9671, 2012 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22308027
2.
BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition.
Eur J Hum Genet
; 14(2): 167-72, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16333312
3.
A loss-of-function genetic screening identifies novel mediators of thyroid cancer cell viability.
Oncotarget
; 7(19): 28510-22, 2016 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27058903
4.
SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas.
Am J Surg Pathol
; 35(7): 937-48, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21677534
5.
The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer.
Eur J Cancer
; 45(8): 1510-7, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19272768
6.
Role of ErbB4 in breast cancer.
J Mammary Gland Biol Neoplasia
; 13(2): 259-68, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18454307
7.
Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer.
Carcinogenesis
; 28(5): 1040-5, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17166884
8.
Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients.
Int J Cancer
; 113(4): 575-80, 2005 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-15472904
9.
CHEK2 variant I157T may be associated with increased breast cancer risk.
Int J Cancer
; 111(4): 543-7, 2004 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-15239132